登入 Remember me (Uncheck if on a shared computer) Forgot your Password ? Please review the fields marked in red and resubmit the form 註冊 成為新會員 Register to access independent medical news and resources from Univadis®
Medical News European Commission approves isatuximab combination therapy for multiple myeloma Univadis Medical News Friday 05 June 2020 The combination therapy significantly improved progression-free survival. Lancet retracts controversial COVID-19 chloroquine study Univadis Medical News Friday 05 June 2020 The much-publicised study found no benefit but significant safety concerns with hydroxychloroquine or chloroquine to treat COVID-19. New French ‘StopCovid’ app downloaded over 600,000 times in 24 hours Univadis Medical News Friday 05 June 2020 Contact tracing app designed to prevent second wave of virus in France. More Medical News > Conference Reports ASCO 2020 - PPI plus chemo yields strikingly high pCR rate in early TNBC Oncology Conference reports Friday 05 June 2020 Phase 2 trial finds pCR rate of 71%, much higher than the 40% expected. ASCO 2020 – Adding pembrolizumab boosts PFS in extensive-stage SCLC Oncology Conference reports Friday 05 June 2020 Adding pembrolizumab offered longer disease-free survival. ASCO 2020 – Avelumab improves survival in patients with advanced urothelial carcinoma Oncology Conference reports Friday 05 June 2020 Research led by Queen Mary University of London and Barts Cancer Institute presented at ASCO 2020. More Conference Reports >
Medical News European Commission approves isatuximab combination therapy for multiple myeloma Univadis Medical News Friday 05 June 2020 The combination therapy significantly improved progression-free survival. Lancet retracts controversial COVID-19 chloroquine study Univadis Medical News Friday 05 June 2020 The much-publicised study found no benefit but significant safety concerns with hydroxychloroquine or chloroquine to treat COVID-19. New French ‘StopCovid’ app downloaded over 600,000 times in 24 hours Univadis Medical News Friday 05 June 2020 Contact tracing app designed to prevent second wave of virus in France. More Medical News >
Conference Reports ASCO 2020 - PPI plus chemo yields strikingly high pCR rate in early TNBC Oncology Conference reports Friday 05 June 2020 Phase 2 trial finds pCR rate of 71%, much higher than the 40% expected. ASCO 2020 – Adding pembrolizumab boosts PFS in extensive-stage SCLC Oncology Conference reports Friday 05 June 2020 Adding pembrolizumab offered longer disease-free survival. ASCO 2020 – Avelumab improves survival in patients with advanced urothelial carcinoma Oncology Conference reports Friday 05 June 2020 Research led by Queen Mary University of London and Barts Cancer Institute presented at ASCO 2020. More Conference Reports >
Featured channels Oncology Oncology essentials all in one place Zika All you need to know about Zika virus
